T-cell Leukemia

10 registered clinical trials studyying T-cell Leukemia — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 NCT06698003	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymp NCT06420076	Essen Biotech	Phase 1 / Phase 2
Completed	Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma NCT04840875	Beijing Boren Hospital	Phase 1
Terminated	LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor NCT04973527	Beijing Boren Hospital	Phase 1
Unknown	Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies NCT04264078	Xinqiao Hospital of Chongqing	EARLY_Phase 1
Recruiting	CD4CAR for CD4+ Leukemia and Lymphoma NCT03829540	Huda Salman	Phase 1
Recruiting	Observatory of Prolymphocytic Leukemia T NCT04411043	French Innovative Leukemia Organisation	—
Completed	Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia ( NCT03792256	Children's Oncology Group	Phase 1
Completed	A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) NCT00611208	Angimmune LLC	Phase 2
Completed	Anti-Tac for Treatment of Leukemia NCT00001941	National Cancer Institute (NCI)	Phase 1 / Phase 2